Protein levels of NT-4/5 appear to be slightly decreased in hippocampus and cerebellum, but mRNA levels are not altered in the parietal cortex of AD patients (Hock et al.1998, 2000a). This evidence concerns the gene NTF4 and Alzheimer disease.